文献速递瓣膜病与结构性心脏病

重度症状性主动脉瓣狭窄的当代管理:EORP VHD II 调查解读

Contemporary Management of Severe Symptomatic Aortic Stenosis.
PubMed 文献 · J Am Coll Cardiol · 2021-01-01

该研究基于 EORP VHD II 调查,分析 1,271 例符合 2012 ESC 指南 I 类推荐的重度症状性高跨瓣压差主动脉瓣狭窄患者的干预决策。结果显示 20.6% 患者未决定干预,未干预与高龄、较低 NYHA 分级、较高共病指数及较低跨瓣平均压差相关,且未干预者 6 个月生存率更低。

要点

  • 约五分之一符合 I 类推荐的重度症状性 AS 患者未决定干预。
  • 未干预决策与高龄、共病负担重、症状较轻及压差较低相关。
  • 未干预者 6 个月生存率显著低于接受干预者。

核心结论

  • 尽管存在 I 类推荐,仍有 1/5 重度症状性 AS 患者未决定干预,尤其与高龄和合并共病相关。

研究设计与样本

  • 基于 EORP VHD II 调查,纳入 2,152 例重度 AS 患者,其中 1,271 例症状性高跨瓣压差 AS 符合 2012 ESC 指南 I 类推荐,主要终点为干预决策。

主要发现

  • 262 例(20.6%)患者决定不干预。
  • 多因素分析显示不干预与年龄较大(每增加 10 岁 OR 1.34,95%CI 1.11-1.61,P=0.002)、NYHA I-II 级 vs III 级(OR 1.63,95%CI 1.16-2.30,P=0.005)、较高年龄校正 Charlson 共病指数(每增加 1 分 OR 1.09,95%CI 1.01-1.17,P=0.03)及较低跨瓣平均压差(每降低 10 mmHg OR 0.81,95%CI 0.71-0.92,P<0.001)相关。
  • 研究期间 346 例(40.2%,中位年龄 84 岁,中位 EuroSCORE II 3.1%)接受经导管干预,515 例(59.8%,中位年龄 69 岁,中位 EuroSCORE II 1.5%)接受外科手术。
  • 不干预 vs 干预与 6 个月生存率较低相关(87.4%,95%CI 82.0-91.3 vs 94.6%,95%CI 92.8-95.9,P<0.001)。

关键数值与推荐

  • 符合 2012 ESC 指南 I 类推荐的重度症状性高跨瓣压差 AS 患者中,20.6% 未决定干预。

临床怎么用

  • 对符合 I 类推荐的重度症状性 AS 患者,应审慎评估未干预决策,尤其高龄共病者需多学科评估。
  • 经导管干预在 octogenarians 中应用广泛,决策时应考虑患者年龄与手术风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There were gaps between guidelines and practice when surgery was the only treatment for aortic stenosis (AS). OBJECTIVES: This study analyzed the decision to intervene in patients with severe AS in the EORP VHD (EURObservational Research Programme Valvular Heart Disease) II survey. METHODS: Among 2,152 patients with severe AS, 1,271 patients with high-gradient AS who were symptomatic fulfilled a Class I recommendation for intervention according to the 2012 European Society of Cardiology guidelines; the primary end point was the decision for intervention. RESULTS: A decision not to intervene was taken in 262 patients (20.6%). In multivariate analysis, the decision not to intervene was associated with older age (odds ratio [OR]: 1.34 per 10-year increase; 95% CI: 1.11 to 1.61; P = 0.002), New York Heart Association functional classes I and II versus III (OR: 1.63; 95% CI: 1.16 to 2.30; P = 0.005), higher age-adjusted Charlson comorbidity index (OR: 1.09 per 1-point increase; 95% CI: 1.01 to 1.17; P = 0.03), and a lower transaortic mean gradient (OR: 0.81 per 10-mm Hg decrease; 95% CI: 0.71 to 0.92; P < 0.001). During the study period, 346 patients (40.2%, median age 84 years, median EuroSCORE II [European System for Cardiac Operative Risk Evaluation II] 3.1%) underwent transcatheter intervention and 515 (59.8%, median age 69 years, median EuroSCORE II 1.5%) underwent surgery. A decision not to intervene versus intervention was associated with lower 6-month survival (87.4%; 95% CI: 82.0 to 91.3 vs 94.6%; 95% CI: 92.8 to 95.9; P < 0.001). CONCLUSIONS: A decision not to intervene was taken in 1 in 5 patients with severe symptomatic AS despite a Class I recommendation for intervention and the decision was particularly associated with older age and combined comorbidities. Transcatheter intervention was extensively used in octogenarians.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Eugène M, Duchnowski P, Prendergast B, et al. Contemporary Management of Severe Symptomatic Aortic Stenosis. J Am Coll Cardiol. 2021. PMID: 34823655. doi:10.1016/j.jacc.2021.09.864

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。